RxDoctor Payments Data

Hannah Badon

Dermatology · Petal, MSNPI 1215556048

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.0% of the total across 218 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,405, 5.9 times the $406 reported in 2021.

$8,754in general payments, 2019–2025

Across 218 payments — averaging $40.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$2K
  • AbbVie$1K
  • E.r. Squibb & Sons, L.L.C.$709
  • Incyte Corporation$629
  • Johnson & Johnson$610
  • Lilly USA, LLC$528
  • plus $4K from 28 others

What the payments were for

  • Food & beverage$8,31595%
  • Education$4395%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,754 in reported general payments places this provider in the 65th percentile of 78 dermatology providers in Mississippi.

See all dermatology providers in Mississippi

Medicare billing

Part B allowed, 2024
$11,426
Medicare patients
41
Services billed
137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab14$154,094
Clobetasol Propionate24$1,232
Clindamycin Phosphate22$1,032
Ketoconazole47$874
Triamcinolone Acetonide40$562
MethotrexateMethotrexate Sodium15$140
Spironolactone19$120
Prednisone14$103
Hydrocortisone14$55
Levothyroxine Sodium11$45

Paid to pharmacies, not to this prescriber.

Other dermatology in Petal

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →